8
Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His- tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2 expression was induced with isopropyl b-d-1- thiogalactopyranoside (IPTG) and the protein purified on a nickel-NTA agarose column. The samples were separated using 12% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Blue. The purified protein is indicated with an arrow. (b). Representative immunoblot (IB) of the expressed OsCYP18-2-His protein probed with the monoclonal anti-His antibody. (a) Purified fra ction OsCYP18-2-His IB : anti-His 70 - 40 - 30 - 50 - 20 - 100 - (kDa) 15 - Insoluble f racti on No Induction Induction Soluble frac tion (b)

Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

Embed Size (px)

Citation preview

Page 1: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2 expression was induced with isopropyl b-d-1-thiogalactopyranoside (IPTG) and the protein purified on a nickel-NTA agarose column. The samples were separated using 12% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Blue. The purified protein is indicated with an arrow. (b). Representative immunoblot (IB) of the expressed OsCYP18-2-His protein probed with the monoclonal anti-His antibody.

(a)

Purified fr

action

OsCYP18-2-His

IB : anti-His

70 -

40 -

30 -

50 -

20 -

100 - (kDa)

15 -

Insoluble f

raction

No Inducti

on

Induction

Soluble fr

action

(b)

Page 2: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

IB: anti-AD

IB : anti-BD

70 -

50 -40 -

30 -

20 -

100 -

(kDa)

BD-OsCYP18-2

AD-OsSKIP Full AD-OsSKIP C-term

AD-OsSKIP N-termAD-OsSKIP N 1-55AD-OsSKIP B 56-95AD

40 -

AD-OsSK

IP Full

AD-OsSK

IP C-term

AD-OsSK

IP N-term

AD-OsSK

IP N 1-55

AD-OsSK

IP B 56-95

AD

BD-OsCYP18-2 Bait :

Prey :

(b)

(a)

pGBKT7 OsCYP18-2 GAL4 BD

pGADT7 OsSKIPsGAL4 AD

SmaI SalI

SmaI XhoI

PADH1

PADH1

Figure S2. Immunoblot analysis of extracts prepared from yeast for the two-hybrid assay. (a) Two sets of plasmids were constructed carrying OsCYP18-2 fused to the GAL4 BD (BD-fusion) and the indicated segments of OsSKIP fused to the GAL4 AD (AD-fusion). The yeast strain AH109 was transformed with different combinations of OsCYP18-2 and OsSKIP plasmids. (b) Immunoblot analysis to assay the expression levels of each fusion protein in whole-cell extract. The immunoblot was probed with anti-BD or anti-AD antibodies.

Page 3: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

SD-LTH+3AT

SD-LT

BD-OsCYP18-2

AD AD-OsS

KIP B

56-9

5

AD-OsS

KIP B

56-9

5

( E

79A)

AD-OsS

KIP B

56-9

5

(E7

9A, H

81A)

SD-LTH+3AT

SD-LT

BD-OsCYP18-2

AD OsSKIP

OsRBM

42

OsPRPF8

OsSF3

B3

OsHDAC8

HsCypD-His

GST-HsBcl2

IB : anti His

IB : anti GST

+ - CsA20 -

(kDa)

15 -

50 -

40 -

Input Bound fraction

+ -

Figure S3. The effect of cyclosporin A (CsA) on recombinant His-tagged HsCypD. The interaction between HsCypD and HsBcl2 was significantly reduced in the presence of CsA. HsCypD-His was immobilized on Ni-NTA agarose beads and incubated with GST-fused HsBcl2. HsCypD was pre-incubated with excess amounts of CsA for 1 h. Immunoblots were probed using anti-His and anti-GST antibodies.

Figure S4. Yeast two-hybrid analysis of the interaction between OsCYP18-2 and OsSKIP B56-95 mutated at the sites E79A or E79A and H81A.

Figure S5. Yeast two-hybrid analysis of interactions of OsCYP18-2 with homologues of candidates PPiL1 interactor (OsRBM42, OsSF3B3, OsPRPF8, OsHDAC8). Information was obtained from IntAct (http://www.ebi.ac.uk/intact/) or BioGRID (http://thebiogrid.org/) databases.

Page 4: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

(b)

Full

N-term

B 56-95

N 1-55

1 71-78 190 356 406 428 563-568 607

1 156

1 55

56 95

1 164

OsCYP18-2-CE-YFP

NE-

YFP-

OsS

KIP

CE-YFPHA

NE-YFP

NE-YFP

NE-YFP

NE-YFPc-myc

SKIP/SNW domain

Glycine-rich box

Bipartite NLS

MonoExtC NLS

CYP domain

(c) OsCYP18-2-CE-YFP

Brig

htYF

P/Ch

loro

plas

t

NE-YFP-Ran1

RanBP1-CE-YFP

NE-YFP-OsSKIP Full

NE-YFP-OsSKIP N-term

NE-YFP-OsSKIP B56-95

NE-YFP-OsSKIP C-term

(d)

70 - 50 -40 -30 -20 -

100 - (kDa)

15 -

IB: anti-HA

B 56

-95

C-te

rm

N-te

rm

Full NE-Y

FP-R

an1

NE-YFP-OsSKIP Ran

BP1

-CE-

YFPOsCYP18-2-CE-

YFP

OsCYP18-2-CE

RanBP1-CE

70 - 50 -40 -

30 -

20 -

100 - (kDa)

15 -

B 56

-95

C-te

rm

N-te

rm

Full

NE-OsSKIP FullNE-OsSKIP C-term

OsSKIP B N-term

OsSKIP B 56-95

NE-YFP-OsSKIP

OsCYP18-2-CE-YFP

NE-Ran1

IB: anti-c-Myc

Ran

BP1

-CE-

YFP

NE-Y

FP-R

an1

OsS

KIP

C-te

rm-G

FP

(a) GFP DAPI Chloro-plast

Merged Bright

OsC

YP18

-2-G

FP

Figure S6. Subcellular localization of OsCYP18-2-GFP and OsSKIP C-term-GFP, and analysis of the interaction between OsCYP18-2 and OsSKIP. (a) Subcellular localization of OsCYP18-2-GFP (upper panel) and OsSKIP C-term-GFP (lower panel) in leaf epidermal cells or protoplast cells from transiently transformed Nicotiana benthamiana plants using the agroinfiltration method. (b) For the bimolecular fluorescence complementation (BiFC) assay, plasmids were constructed containing OsCYP18-2 fused to pSPYCE and different fragments of OsSKIP fused to pSPYNE. Different combinations of plasmids were introduced into N. benthamiana leaves using Agrobacterium GV3101 infiltration. (c) BiFC visualization of OsCYP18-2 and OsSKIPs interactions. (d) The expression level of each fusion protein in N. benthamiana leaf extract was assayed using immunoblot analysis with anti-HA or anti-c-Myc antibodies. A combination of RanBP1-CE-YFP and NE-YFP-Ran1 was used as a positive control. Scale bars: 20 μm.

Page 5: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

OsCYP18-2-GFP + SKIP Full(b)

Distance (µm)

Inte

nsity

Ch2 : GFPChS1 : ChloroplastChD : Bright

(d)

(f)

(c)

Inte

nsity

Distance (µm)

Ch2 : GFPChS1 : ChloroplastChD : Bright

(a) OsCYP18-2-GFP + SKIP B56-95

(e)

Figure S7. Quantification of fluorescence in the cytoplasm and nucleus. (a,b) Fluorescence and bright-field merged representative images of epidermal cells after transient expression of OsCYP18-2-GFP and SKIP B56-95/SKIP Full (NE-YFP-OsSKIP Full or AtSKIP Full-HA). (c,d) Quantitation of GFP fluorescence in the nucleus and cytoplasm along the scanned lines (red arrow) in images (a,b) using the LSM5 image program (Carl Zeiss Laser Scanning System LSM 510). The profile shows the intensity of GFP fluorescence (green) and chloroplast autofluorescence (red) along with distance. (e,f) Values are maximum fluorescence intensities in the nucleus and cytoplasm and autofluorescence in the chloroplast. All images were captured at same focal planes and with the same laser intensity.

Page 6: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

(a)

pCAMBIA1300-OsCYP18-2

T-NOSOsCYP18-2 RBLB HPTII

SpeI KpnI

35S-P 35S-PT-NOS

OsCYP18-2

AtACT2

WT V1 OE1 OE2 OE3

AtCYP18-2

At

(b)

OsCYP18-2OsACT1

OE1 OE2 OE3

WT 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Os (T1)

WT OE1 OE2 OE3Os (T2)

OsCYP18-2

OsACT1

(c)

OsCYP18-2

WT OE1 OE2 OE3Os

Ponceau S

IB: anti-OsCYP18-2

20 -(kDa)

15 -

WT OE1 OE2 OE3At

OsCYP18-2AtCYP18-2

Ponceau S

IB: anti-OsCYP18-2

20 -(kDa)

15 -

Figure S8. Constitutive expression of OsCYP18-2 in rice and Arabidopsis. (a) Structure of the pCAMBIA1300 binary vector harbouring OsCYP18-2 under the control of the 35S promoter. (b) Ectopic and constitutive expression of OsCYP18-2 in the T1 (14 lines) and T2 (OE1, OE2, OE3) generations of transgenic rice and in T3 homozygous Arabidopsis plants was compared with that in WT plants or vector controls using semi-quantitative RT-PCR analysis. AtACT2 and OsACT1 were used as controls for mRNA normalization. V1: pCAMBIA vector control transgenic plants; At: OsCYP18-2-expressing transgenic Arabidopsis plants; WT: wild-type plants; Os: OsCYP18-2 transgenic rice plants. (c) Immunoblot analysis of the OsCYP18-2 over-expressing plants using anti-OsCYP18-2 antibody.

Page 7: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

WT V1 OE1 OE2 OE30

50

100

150

200

250(a)

Stom

atal

den

sity

(no/

mm

²)

Vector OsCYP18-2 OE (b)

Figure S9. Stomatal density and stomatal aperture in leaves of Arabidopsis plants over-expressing OsCYP18-2 and in leaves of vector control and wild-type plants. (a) Stomatal density under normal conditions. (b) Photographs showing stomatal closure (arrowheads) under drought-stress conditions in leaf epidermal cells of OsCYP18-2 OE and vector control Arabidopsis plants. Scale bar: 20 μm.

Page 8: Figure S1. Purification of OsCYP18-2 from E. coli. (a) Recombinant His-tagged OsCYP18-2 was cloned into pET28a. Following transformation of E. coli, OsCYP18-2

BD

BD-OsSKIP

BD-OsSKIP C-term

BD-OsCYP 18-2

positive

0 5 10 15 20 25 30

+

+

+

+

SD/-W/X-α-gal

_

SD/-WH

BD

BD-OsSKIP

BD-OsSKIP C-term

BD-OsCYP18-2

BD-AD

0 0.5 1

(b)

α-Galactosidase activity (PNP- α-gal)

(a)SmaI SalI

pGBKT7 PADH1 GAL4 BD TADH1&T7

AD/OsCYP18-2/OsSKIP C-term/OsSKIP

Figure S10. Transcriptional activation analysis of OsCYP18-2 using a yeast one-hybrid system derived from the GAL4 two-hybrid system. (a) OsCYP18-2 and OsSKIP or OsSKIP deletion constructs were used. pGBKT7 was used as the effector plasmid and yeast strain AH109 was used as the reporter yeast. (b) Tran-scriptional activation was monitored by assaying α-galactosidase activity (left) and yeast growth on -Trp media containing X-α-gal or -Trp-His media (right). The plasmids pGBKT7-OsSKIP or pGBKT7-OsSKIP deletion forms and pGBKT7 were used as the positive and negative controls, respectively.